EQUASENS (EQS.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:EQS - FR0012882389 - Common Stock
42.45 EUR
-0.15 (-0.35%)
EQS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 11 industry peers in the Health Care Technology industry. While EQS has a great profitability rating, there are some minor concerns on its financial health. EQS has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
EQS had positive earnings in the past year.
In the past year EQS had a positive cash flow from operations.
Each year in the past 5 years EQS has been profitable.
Each year in the past 5 years EQS had a positive operating cash flow.
1.2 Ratios
EQS has a better Return On Assets (8.84%) than 72.73% of its industry peers.
EQS's Return On Equity of 15.79% is amongst the best of the industry. EQS outperforms 90.91% of its industry peers.
EQS's Return On Invested Capital of 12.70% is amongst the best of the industry. EQS outperforms 90.91% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EQS is significantly above the industry average of 9.28%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.84% | ||
| ROE | 15.79% | ||
| ROIC | 12.7% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
1.3 Margins
EQS's Profit Margin of 16.15% is amongst the best of the industry. EQS outperforms 81.82% of its industry peers.
EQS's Profit Margin has been stable in the last couple of years.
EQS's Operating Margin of 19.80% is amongst the best of the industry. EQS outperforms 81.82% of its industry peers.
EQS's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 68.81%, EQS is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
EQS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.8% | ||
| PM (TTM) | 16.15% | ||
| GM | 68.81% |
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), EQS is creating value.
EQS has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, EQS has more shares outstanding
Compared to 1 year ago, EQS has an improved debt to assets ratio.
2.2 Solvency
EQS has an Altman-Z score of 3.96. This indicates that EQS is financially healthy and has little risk of bankruptcy at the moment.
EQS has a Altman-Z score of 3.96. This is in the better half of the industry: EQS outperforms 72.73% of its industry peers.
The Debt to FCF ratio of EQS is 0.98, which is an excellent value as it means it would take EQS, only 0.98 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 0.98, EQS is doing good in the industry, outperforming 72.73% of the companies in the same industry.
EQS has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.09, EQS is doing good in the industry, outperforming 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.98 | ||
| Altman-Z | 3.96 |
ROIC/WACC1.64
WACC7.76%
2.3 Liquidity
EQS has a Current Ratio of 1.29. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
EQS has a Current ratio (1.29) which is in line with its industry peers.
EQS has a Quick Ratio of 1.20. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.20, EQS perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.2 |
3. Growth
3.1 Past
EQS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.07%.
The Earnings Per Share has been growing slightly by 5.12% on average over the past years.
Looking at the last year, EQS shows a small growth in Revenue. The Revenue has grown by 4.45% in the last year.
The Revenue has been growing slightly by 6.45% on average over the past years.
EPS 1Y (TTM)-14.07%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
3.2 Future
Based on estimates for the next years, EQS will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.63% on average per year.
Based on estimates for the next years, EQS will show a small growth in Revenue. The Revenue will grow by 7.74% on average per year.
EPS Next Y13%
EPS Next 2Y17.52%
EPS Next 3Y18.63%
EPS Next 5YN/A
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 17.76 indicates a rather expensive valuation of EQS.
Compared to the rest of the industry, the Price/Earnings ratio of EQS indicates a somewhat cheap valuation: EQS is cheaper than 72.73% of the companies listed in the same industry.
EQS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.59.
EQS is valuated correctly with a Price/Forward Earnings ratio of 13.41.
Based on the Price/Forward Earnings ratio, EQS is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
EQS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.80, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.76 | ||
| Fwd PE | 13.41 |
4.2 Price Multiples
81.82% of the companies in the same industry are more expensive than EQS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, EQS is valued a bit cheaper than 72.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.34 | ||
| EV/EBITDA | 8.84 |
4.3 Compensation for Growth
EQS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
EQS has a very decent profitability rating, which may justify a higher PE ratio.
EQS's earnings are expected to grow with 18.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.37
PEG (5Y)3.47
EPS Next 2Y17.52%
EPS Next 3Y18.63%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.91%, EQS has a reasonable but not impressive dividend return.
EQS's Dividend Yield is comparable with the industry average which is at 4.12.
EQS's Dividend Yield is a higher than the S&P500 average which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.91% |
5.2 History
On average, the dividend of EQS grows each year by 8.00%, which is quite nice.
Dividend Growth(5Y)8%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
EQS pays out 51.75% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of EQS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP51.75%
EPS Next 2Y17.52%
EPS Next 3Y18.63%
EPA:EQS (12/10/2025, 7:00:00 PM)
42.45
-0.15 (-0.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners11.63%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap643.97M
Revenue(TTM)224.73M
Net Income(TTM)36.30M
Analysts82.86
Price Target52.36 (23.35%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.91% |
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.75%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.76%
PT rev (3m)3.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-4.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.76 | ||
| Fwd PE | 13.41 | ||
| P/S | 2.87 | ||
| P/FCF | 17.34 | ||
| P/OCF | 13.34 | ||
| P/B | 2.8 | ||
| P/tB | 8.06 | ||
| EV/EBITDA | 8.84 |
EPS(TTM)2.39
EY5.63%
EPS(NY)3.17
Fwd EY7.46%
FCF(TTM)2.45
FCFY5.77%
OCF(TTM)3.18
OCFY7.49%
SpS14.81
BVpS15.16
TBVpS5.27
PEG (NY)1.37
PEG (5Y)3.47
Graham Number28.55
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.84% | ||
| ROE | 15.79% | ||
| ROCE | 15.59% | ||
| ROIC | 12.7% | ||
| ROICexc | 17.92% | ||
| ROICexgc | 69.44% | ||
| OM | 19.8% | ||
| PM (TTM) | 16.15% | ||
| GM | 68.81% | ||
| FCFM | 16.53% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.36%
ROICexc(5y)21.38%
ROICexgc(3y)50.59%
ROICexgc(5y)62.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexgc growth 3Y-25.09%
ROICexgc growth 5Y-9.54%
ROICexc growth 3Y-15.77%
ROICexc growth 5Y-10.18%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.98 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 69.34% | ||
| Cap/Sales | 4.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.71% | ||
| Profit Quality | 102.29% | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.2 | ||
| Altman-Z | 3.96 |
F-Score7
WACC7.76%
ROIC/WACC1.64
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-14.07%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
EPS Next Y13%
EPS Next 2Y17.52%
EPS Next 3Y18.63%
EPS Next 5YN/A
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
EBIT growth 1Y-8.02%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year59.12%
EBIT Next 3Y27.46%
EBIT Next 5YN/A
FCF growth 1Y-36.73%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-31.7%
OCF growth 3Y0.02%
OCF growth 5Y3.18%
EQUASENS / EQS.PA FAQ
What is the ChartMill fundamental rating of EQUASENS (EQS.PA) stock?
ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA.
What is the valuation status for EQS stock?
ChartMill assigns a valuation rating of 6 / 10 to EQUASENS (EQS.PA). This can be considered as Fairly Valued.
What is the profitability of EQS stock?
EQUASENS (EQS.PA) has a profitability rating of 7 / 10.
What is the expected EPS growth for EQUASENS (EQS.PA) stock?
The Earnings per Share (EPS) of EQUASENS (EQS.PA) is expected to grow by 13% in the next year.
Can you provide the dividend sustainability for EQS stock?
The dividend rating of EQUASENS (EQS.PA) is 6 / 10 and the dividend payout ratio is 51.75%.